AV-412
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AV-412, covering 2011-10-04 to 2011-10-04. Get the full timeline:
Most recent: Clinical Trial Update: A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients [Phase 1]